Fundraising FoxManaT Bio
Baltimore, US · Founded 2020 · Delaware corporation · 5 known investors
Find your way into ManaT Bio
Sign up to find every way you can get introduced to ManaT Bio
- Your email: who you already know at ManaT Bio, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the ManaT Bio team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
CG
Cary G. PfefferNamed on SEC filing
RJ
R. Jacob VogelsteinNamed on SEC filing
AV
Andrea Van ElsasNamed on SEC filing
RC
Raymond CamahortNamed on SEC filing
JN
Jack NielsenNamed on SEC filing
AP
Andrew PardollNamed on SEC filing
Investors · 5
Catalio Capital ManagementreportedNew York
How we know: funding news · Not right? Tell us
Novo HoldingsreportedCopenhagen · $1.1M – $54M
How we know: funding news · Not right? Tell us
Revo CapitalreportedIstanbul · $250K – $5M
How we know: press coverage · Not right? Tell us
Third Rock VenturesreportedBoston · $100K – $5M
How we know: funding news · Not right? Tell us
Vivo CapitalreportedPalo Alto · $10M – $50M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$72.1M disclosed across 1 round · 2023
▶$72.1MraisedOct 2023 · 9 investors · BiotechnologyRule 506(b)
▶$72.1MraisedOct 2023 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Cary G. PfefferExecutive Officer, Director
- R. Jacob VogelsteinDirector
- Andrea Van ElsasExecutive Officer, Director
- Raymond CamahortDirector
- Jack NielsenDirector
- Andrew PardollDirector
- ManaT Holdings, LLCPromoter
- Offering amount
- $153M
- Amount sold
- $72.1M
- First sale
- Oct 2023
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are ManaT Bio's investors?
- ManaT Bio's investors include Catalio Capital Management, Novo Holdings, Revo Capital, Third Rock Ventures, Vivo Capital.
- How much funding has ManaT Bio raised?
- ManaT Bio has disclosed $72.1M raised across 1 round.
- Where is ManaT Bio headquartered?
- ManaT Bio is headquartered in Baltimore, US.